Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.
- Published In:
- Drug safety, 47(5), 439-451 (2024)
- Database ID:
- RPEP-07919
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07919APA
Calvarysky, Bronya; Dotan, Idit; Shepshelovich, Daniel; Leader, Avi; Cohen, Talia Diker. (2024). Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.. Drug safety, 47(5), 439-451. https://doi.org/10.1007/s40264-023-01392-3
MLA
Calvarysky, Bronya, et al. "Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.." Drug safety, 2024. https://doi.org/10.1007/s40264-023-01392-3
RethinkPeptides
RethinkPeptides Research Database. "Drug-Drug Interactions Between Glucagon-Like Peptide 1 Recep..." RPEP-07919. Retrieved from https://rethinkpeptides.com/research/calvarysky-2024-drugdrug-interactions-between-glucagonlike
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.